Claims
- 1. A method for treating noncontagious psoriasis, comprising intraveneously administering a pharmaceutical composition, consisting essentially of an effective anti-psoriatic amount of tumor necrosis factor and at least one pharmaceutically acceptable carrier or diluent, to a patient having psoriasis.
- 2. The method according to claim 1, wherein said tumor necrosis factor is produced from a human derived cell.
- 3. The method according to claim 1, wherein said tumor necrosis factor is produced by means of recombinant DNA technique.
Parent Case Info
This is a continuation of application Ser. No. 07/704,686, filed May 17, 1991, now abandoned, which is a continuation of application Ser. No. 07/290,497, filed Dec. 27, 1988, now abandoned.
US Referenced Citations (3)
Foreign Referenced Citations (1)
Number |
Date |
Country |
0158286 |
Oct 1985 |
EPX |
Continuations (2)
|
Number |
Date |
Country |
Parent |
704686 |
May 1991 |
|
Parent |
290497 |
Dec 1988 |
|